Fagron NV operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fagron NV with three other pharmaceutical manufacturers in Europe: Dechra Pharmaceuticals PLC of UNITED KINGDOM (2019 sales of £481.80 million [US$589.72 million] of which 63% was European Pharmaceuticals), Boiron SA of FRANCE (557.12 million Euros [US$611.55 million] ), and Evotec SE which is based in GERMANY (446.44 million Euros [US$490.05 million] of which 76% was EVT Execute).

Sales Analysis. During the year ended December of 2019, sales at Fagron NV were 534.70 million Euro (US$586.93 million). This is an increase of 13.4% versus 2018, when the company's sales were 471.68 million Euro. This was the third consecutive year of growth at Fagron NV.